ArticleThe Lancet regional health. Europe2026

Estimation of Future Patient Populations Eligible for Radioligand Therapies in the EU and the UK: A Modelling Study.

Uwe Holzwarth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.